Библиография

1. Митов Г., Капрелян Г., Димитров Д., Тягуненко Ю., Маринова Р., Златев 
Ст., Денчев В., Хаджиев С., Петровски С.: Микробиология; Мед и физк., София
1988, стр. 197–204
2. Hooton TM, Scholes D, Hughes JP, et al.: A prospective study of risk factors
for symptomatic urinary tract infections in young women. N Engl J Med 355: 468–474,
1996
3. Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA.
Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA. 1994 Mar
9; 271(10): 751–4
4. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness
of naturopathic cranberry products as prophylaxis against urinary tract infections in
women. Can J Urol. 2002 Jun; 9(3): 1558–1562
5. Sobota AE. Inhibition of bacterial adherence by cranberry juice: Potential use
for the treatment of urinary tract infections. J Urol 1984; 131: 10136
6. Dignam R, Ahmed M, Denman S, et al. The effect of cranberry juice on UTI
rates in a long term care facility. J Am Geriatr Soc 1997; 45: S53
7. Walker EB, Barney DP, Mickelsen JN, et al. Cranberry concentrate: UTI
prophylaxis. J Family Pract 1997; 45: 16708 [letter]
8. Schlager TA, Anderson S, Trudell J, Hendley JO. Effect of cranberry juice on
bacteriuria in children with neurogenic bladder receiving intermittent catheterization. J
Pediatr 1999; 135: 6980702
9. Ofek I, Goldhar J, Zafriri D, et al. Anti-Escherichia coli adhesion activity of
cranberry and blueberry juices. N Engl J Med 1991; 324: 1599
10. Ofek I, Goldhar J, Esltdat Y, Sharon N. The importance of mannose specific
adhesins (lectins) in infections caused by Escherichia coli. Scand J Infect Dis Suppl
1982; 33: 6107
11. Toyota S, Fukushi Y, Katoh S, et al. Anti-bacterial defense mechanism of the
urinary bladder. Role of mannose in urine. Nippon Hinyokika Gakkai Zasshi 1989; 80:
1816023 [in Japanese]
12. Larsson B, Jonasson A, Fianu S. Prophylactic effect of UVA-E in women with
recurrent cystitis: a preliminary report. Curr Ther Res 1993; 53: 441–3
13. Yarnell E. Botanical medicines for the urinary tract. World J Urol. 2002 Nov;
20(5): 285–293
14. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete German
Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American
Botanical Council and Boston: Integrative Medicine Communications, 1998, 22405
15. Asahara T, Nomoto K, Watanuki M, Yokokura T. Antimicrobial activity
of intraurethrally administered probiotic Lactobacillus casei in a murine model of
Escherichia coli urinary tract infection. Antimicrob Agents Chemother. 2001 Jun; 45(6):
1751–60
16. Association of P and other Fimbriae with Clinical Pyelonephritis in Children
J. Elo, L. G. Tallgren, V. Vдisдnen, T. K. Korhonen, S. B. Svenson and P. H. Mдkelд
http://informahealthcare.com/doi/abs/10.3109/00365598509180270
17. Joaquim Ruiz, 2002, Differences in Virulence Factors among Clinical Isolates
of E. coli Causing Cystitis and Pyelonephritis in Women and Prostatis in Men, Journal
of Clin. Microbiol. Dec. 2002, p. 4445–4449
18. Johnson, J.R. 1991. Virulence factors of E. coli UTIs. Clin. Microbiol. Rev. 4:
80–128)
19. Neureus W. G IV, 2001, In Vivo Dynamics of Type 1 Fimbria Regulation in
Uropathogenic E. coli during Experimental UTI, Infection and Immunity, p. 2838–2846
20. Neureus W. G IV, 2001, In Vivo Dynamics of Type 1 Fimbria Regulation in
Uropathogenic E. coli during Experimental UTI, Infection and Immunity, p. 2838–2846
21. Fox CC, Wolf EJ, Kagey-Sobotka A, et al: Comparison of human lung and
intestinal mast cell. J Allerg Clin Immunol 1988; 81: 89–94
22. Bronner C, Landry Y: Kinetics of the inhibitory effect of flavonoids on histamine
secretion from mast cells. Agents Actions 1985; 16: 147–151
23. Della Loggia, Ragazzi E, Tubaro A, et al: Anti-inflammatory activity of
benzoppyrones that are inhibitors of cyclo-and lipo-oxygenase. Pharmacol Res
Commun 1988; 20: S91–S94
24. Kim HP, Mani I, Ziboh VA: Effects of naturally-occurring flavonoids and
biflavonoids on epiderman cyclooxygenase from guinea pigs. Prostaglandins Leukot
Essent Fatty Acids 1998; 58: 17–24
25. Jentsch, Thomas J., Valentin Stein, Frank Weinreich, and Anselm A. Zdebik.
Molecular Structure and Physiological Function of Chloride Channels. Physiol. Rev. 82:
503–568, 2002
26. Letz B, Korbmacher C.cAMP stimulates CFTR-like Cl- channels and inhibits
amiloride-sensitive Na+ channels in mouse CCD cells. Am J Physiol. 1997 Feb; 272 (2
Pt 1): C657–66
27. Dixon, R. A., P. M. Dey, and C. J. Lamb. 1983. Phytoalexins: enzymology and
molecular biology. Adv. Enzymol. 55: 1–69
28. Marjorie Murphy Cowan Plant Products as Antimicrobial Agents, Clinical
Microbiology Reviews, October 1999, p. 564–582, Vol. 12, No. 4
29. Haslam, E. 1996. Natural polyphenols (vegetable tannins) as drugs: possible
modes of action. J. Nat. Prod. 59: 205–215
30. Scalbert, A. 1991. Antimicrobial properties of tannins. Phytochemistry
30:3875-3883. Петков В. Betula pendula Roth. В кн.: Съвременна фитотерапия.
Под ред. на В. Петков Мед. и физк., София, 1982, стр. 267–268
31. Akilama T, Ishida J, Nakagawa T et al: Genistein, a specific inhibitor of tyrosine-
specific protein kinase J Biol Chem 1987; 262: 5592–5
32. Blumenthal, M., Therapeutic Monographs on Medicinal Plants for Human Use
1993
33. Brandi ML: Flavonoids Biochemical effects and therapeutic applications, Bone
Miner 1992; 19: 35–145
34. Busse WW, Kopp DE, Middleton E. Flavonoid modulation of human neutrophil
function. J Allerg Clin Immunol 1984; 73: 801–9
35. Carnat A, Lacouture I, Fraisse D, Lamaison JL. Standardization of the birch
leaf] Ann Pharm Fr. 1996; 54(5): 231–5
36. Zarudii FS, Galin FZ, Spirikhin LV, Tolstikov GA, Pliasunova OA. Synthesis and
pharmacological activity of betulin dinicotinate. Bioorg Khim. 2002 Nov-Dec; 28(6):
543–50
37. Ellianowska A. et Kaczmarek F., Herba pol., 1966, 11, 47.from Betula platyphylla
var. japonica. Life Sci. 2004 Jan 9; 74(8): 1013–26
38. Hirano T, Oka K, Akiba M. Antiproliferative activity of synthetic and naturally
occurring flavonoids on tumor cells of the human breast carcinoma cell line ZR 75-1.
Res Commun Pathol Pharmacol 1989; 64: 69–78
39. Leclerc H., Rev. Phytotherap., 1938, 2, 6535
40. Middleton E, Drzewieki G. Naturally occurring flavonoids and human basophil
histamine release. Arch Allerg Applied Immunol 1985; 77: 155–7
41. Middleton C Jr, Drzewiecki G, Krishnarao D. J Immunol 1981; 127: 546
42. Moore, M. Herbal Energetic Charts, 1995
43. Paris R.R. et Moyse H., in‚ Matiere Medicale‘, T.2,P.92, Masson Ed., Paris,
1981
44. Pizzorno JE, Murray MT. A Textbook of Natural Medicine, Quercetin. John
Bastyr College Publications, Seattle, 1987, pp.V: Querc-1-Querc-5
45. Sur TK, Pandit S, Battacharyya D, Kumar CK, Lakshmi SM, Chatttopadhyay D,
Mandal SC. Studies on the antiinflammatory activity of Betula alnoides bark. Phytother
Res. 2002 Nov; 16(7): 669–71
46. Salminen JP, Ossipov V, Pihlaja K. Distribution of hydrolysable tannins in the
foliage of Finnish birch species. Z Naturforsch [C]. 2002 Mar-Apr; 57(3–4): 248–56
47. Tissut M. et Ravanel P., Phytochemistry, 1980, 19, 2077
48. Weiss, R.F. Herbal Medicine. Beaconsfield, England: Beaconsfield Publishers
Ltd. 1988
49. Wichtl M (ed). 1994. Betulae folium - Birch leaf. In Herbal Drugs and Phyto-
pharmaceuticals. (English translation by Norman Grainger Bisset). CRC Press, Stuttgart,
pp. 106–108
50. Stern, J. L., A. E. Hagerman, P. D. Steinberg, and P. K. Mason. 1996.
Phlorotannin-protein interactions. J. Chem. Ecol. 22: 1887–1899
51. Ya, C., S. H. Gaffney, T. H. Lilley, and E. Haslam. 1988. Carbohydrate-polyphenol
complexation, p. 553. In R. W. Hemingway, and J. J. Karchesy (ed.), Chemistry and
significance of condensed tannins. Plenum Press, New York, N.Y
52. Kaul, T. N., E. Middletown, Jr., and P. L. Ogra. 1985. Antiviral effect of
flavonoids on human viruses. J. Med. Virol. 15: 71–79
53. Nonaka, G.-I., I. Nishioka, M. Nishizawa, T. Yamagishi, Y. Kashiwada, G. E.
Dutschman, A. J. Bodner, R. E. Kilkuskie, Y.-C. Cheng, and K.-H. Lee. 1990. Anti-AIDS
agents. 2. Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication
in H9 lymphocyte cells. J. Nat. Prod. 53: 587–595
54. Barre, J. T., B. F. Bowden, J. C. Coll, J. Jesus, V. E. Fuente, G. C. Janairo, and
C. Y. Ragasa. 1997. A bioactive triterpene from Lantana camara. Phytochemistry 45:
321–324
55. Himejima, M., K. R. Hobson, T. Otsuka, D. L. Wood, and I. Kubo. 1992.
Antimicrobial terpenes from oleoresin of ponderosa pine tree Pinus ponderosa: a
defense mechanism against microbial invasion. J. Chem. Ecol. 18: 1809–1818
56. Scortichini, M., and M. Pia Rossi. 1991. Preliminary in vitro evaluation of the
antimicrobial activity of terpenes and terpenoids towards Erwinia amylovora (Burrill)
Winslow et al. J. Appl. Bacteriol. 71: 109–112
57. Taylor, R. S. L., F. Edel, N. P. Manandhar, and G. H. N. Towers. 1996.
Antimicrobial activities of southern Nepalese medicinal plants. J. Ethnopharmacol. 50:
97–102
58. Ross JA, Kasum CM.Dietary flavonoids: bioavailability, metabolic effects, and
safety. Annu Rev Nutr. 2002; 22: 19–34. Epub 2002 Jan 04
59. Middleton E Jr, Kandaswami C. The impact of plant flavonoids on mammalian
biology: implications for immunity, inflammation and cancer. Chapter 15 in: Harbourne
JB (Ed). The flavonoids: advances in research since 1986. Chapman & Hall, London,
1993; 619–652
60. Middleton E, Kandaswami C. Effects of flavonoids on immune and
inflammatory cell functions. Biochem Pharmacol 1992; 43(6): 1167–1179
61. Groff JL, Gropper SS, Hunt SM. Advanced Nutrition and Human Metabolism.
West Publishing Company, New York, 1995
62. Hertog MGL, Feskens EJM, Hollman PCH, et al. Dietary flavonoids and cancer
risk in the Zutphen elderly study. Nutr Cancer 1994; 22: 175–84
63. Castillo MH, Perkins E, Campbell JH, et al. The effects of the bioflavonoid
quercetin on squamous cell carcinoma of head and neck origin. Am J Surg 1989;
351–5
64. Stavric B. Quercetin in our diet: from potent mutagen to probably
anticarcinogen. Clin Biochem 1994; 27: 245–8
65. Barotto NN, Lуpez CB, Eyard AR, et al. Quercetin enhances pretumourous
lesions in the NMU model of rat pancreatic carcinogenesis. Cancer Lett 1998;
129: 1–6
66. Stoewsand GS, Anderson JL, Boyd JN, Hrazdina G. Quercetin: a mutagen, not
a carcinogen in Fischer rats. J Toxicol Environ Health 1984; 14: 105–14
67. Hollman, P. C., Bijsman, M. N., van Gameren, Y., Cnossen, E. P., de Vries, J. H.
and Katan, M.B. 1999. The sugar moiety is a major determinant of the absorption of
dietary flavonoid glycosides in man. Free Radic. Res. 31: 569–573
68. Lai, M. Y., Hou, Y. C., Hsiu, S. L., Chen, C. C. and Chao, P. D. L. 2002.
Relative flavone bioavailability of Scutellariae Radix between traditional decoction and
commercial powder preparation in humans. J. Food Drug Anal. 10: 75–80. heterocyclic
amine mutagens from cooked food. Mutat. Res. 287: 261–274
69. Iris Erlund, Chemical analysis and pharmacokinetics of the flavonoids
quercetin, hesperetin and naringenin in humans, Publications of the National Public
Health Institute (KTL) A27/2002, Mannerheimintie 166, Helsinki, FINLAND, 2002
70. Hodaek, P., Trefil, P. and Stiborova, M. 2002. Flavonoids-potent and versatile
biologically active compounds interacting with cytochromes P450. Chemico-Biol. Inter.
139: 1-21. cytochrom P450 3A4. Biochem. 36: 370-381
71. Bok-Dohalska, L., Hodek, P., Sulc, M. and Stiborova, M. 2001. — Naphthoflavone
acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP 3A6.
Chem. Biol. Interact. 138: 85–106
72. Tsyrlov, I. B., Mikhailenko, V. M. and Gelboin, H. V. 1994. Isozyme- and species-
specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids.
Biochim. Biophys. Acta. 1205: 325–335
73. Hsiu, S. L., Hou, Y. C., Su, S. F., Wang, Y. H., Tsao, C. W. and Chao, P. D. L.
2002. Quercetin Inhibits Cyclosporin Absorption in Pigs and Rats. Life Sci